AVAX Technologies, Inc. (AVAX) is a development stage biotechnology company specializing in the development and future commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. The Company's vaccine consists of autologous (the patient’s own) cancer cells that have been treated with a chemical (haptenized) to make them more visible to the patient’s immune system. AVAX refer to its cancer vaccine technology as autologous cell vaccine immunotherapy and to the vaccine as the AC Vaccine. Its clinical trials for the AC Vaccine have concentrated on melanoma, ovarian carcinoma, which are its primary indications, and non-small cell lung cancer. The Company refers to its AC Vaccine candidates as: M-Vax, L-Vax and O-Vax. M-Vax is for the treatment of melanoma. L-Vax is for the treatment of non-small cell lung cancer. O-Vax is for the treatment of ovarian cancer.
Website:
AVAX



LinkBack URL
About LinkBacks
Reply With Quote
